Opill Tablet
Product Images NDC 67296-1938

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Opill (NDC 67296-1938). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clock (Image 01)

FDA Label Image

Condom (Image 02)

FDA Label Image

Female-outline (Image 03)

Female-outline (Image 03)
This text discusses a form of contraception called an IUD which acts by thickening cervical mucus to block sperm from reaching the egg.*
FDA Label Image

Tier-one (Image 04)

FDA Label Image

Tier-two (Image 05)

FDA Label Image

Tiers (Image 06)

Tiers (Image 06)
This text appears to list various methods of contraception and fertility awareness, including condom-based methods, withdrawal, spermicides, female condoms, diaphragms, and sponges. It provides basic information on the available options for birth control and reproductive health.*
FDA Label Image

Opill-pdp (Image 07)

Opill-pdp (Image 07)
This is a description of Norgestrel tablets 0.075mg, a daily oral contraceptive. The package contains the full prescription strength. It is recommended to take one tablet at the same time every day. It reminds the user not to use it as an emergency contraceptive. The origin of the drug is indicated in the text as "product of Germany." The text also mentions that the tablets are FDA approved.*
FDA Label Image

Opill-dfl-one (Image 08)

Opill-dfl-one (Image 08)
This is a description of "Opill Norgestrel tablets 0.075mg," which is a daily oral contraceptive. The text provides information on the active ingredient, purpose, warnings, and directions for use. It includes details such as possible side effects, precautions, and when to seek medical help while using this contraceptive. Additionally, it mentions the importance of taking the tablet at the same time daily and using additional protection during the first two days of use for optimal effectiveness in preventing pregnancy.*
FDA Label Image

Opill-dfl-two (Image 09)

Opill-dfl-two (Image 09)
This text contains drug facts and directions for a certain medication. It advises on how to take daily tablets properly to prevent pregnancy and what to do in case of missing a dose. It also mentions using a condom for the next 2 days after missing a pill. Additionally, it includes information on storing the medication, inactive ingredients, and how to seek further assistance or report any issues. It is essential to read the instructions, warnings, and product leaflet before use.*
FDA Label Image

Reminder-card-front (Image 10)

Reminder-card-front (Image 10)
This text provides important instructions for taking a tablet as a form of contraception. It emphasizes the importance of taking the tablet daily at the same time without any breaks, even if there are changes in the menstrual period. In case a tablet is late or missed, it advises using backup contraception for 2 days. It also mentions referring to the Drug Facts and consumer information leaflet for additional details.*
FDA Label Image

Reminder-card-back (Image 11)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.